Neumora Therapeutics, Inc. Common Stock
NMRA •
Sell Open
Signal type
Sell
Status
Open
Open Price
$2.51
Stop Loss
$3.68
Performance
19.12%
Days Open
27
Signal Setup
Signal Type Sell
Status Open
Open Date Mar 19, 2026
Open Price $2.51
Stop Loss $3.68
Timespan Day
Company Profile
Name Neumora Therapeutics, Inc. Common Stock
Ticker NMRA
Market Cap $128.80M
Sector BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Latest Close $2.03
List Date Sep 15, 2023
Description
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
Website Open Company Website